EPISODE · Dec 29, 2022 · 23 MIN
Top 5 medical innovations of 2022
from 20-Minute Health Talk · host Northwell Health
As 2022 comes to a close, we look back on five exciting medical advances coming from clinical researchers at Northwell Health and the health system's Feinstein Institutes for Medical Research. In the last year alone, investigators published more than 2,500 papers in peer-reviewed journals. In this episode, we spotlight studies that made strides against endometriosis, diabetes, lupus, pancreatic cancer and (yes) Covid-19. Read more about these Five notable Northwell advances of 2022. Chapters: 02:05 – Treating pancreatic cancer in a petri dish | Matthew Weiss, MD 05:51 – A powerful lupus treatment in the pipeline | Richard Furie, MD 10:25 – Famotidine for Covid | Tobias Janowitz, MD, PhD 14:45 – A noninvasive test for endometriosis | Christine Metz, PhD 19:12 – Treating diabetes with ultrasound | Sangeeta Chavan, PhD Meet our guests: Matthew Weiss, MD, professor in the Institute of Cancer Research at the Feinstein Institutes and the deputy physician-in-chief and surgical director in the Cancer Institute at Northwell Health Richard Furie, MD, chief of the Division of Rheumatology at Northwell and global principal investigator on the LILAC (Part A) clinical trial Tobias Janowitz, MD, PhD, assistant professor, Cold Spring Harbor Laboratory; adjunct professor at the Feinstein Institutes; and principal investigator of the trial studying famotidine for Covid Christine Metz, PhD, professor in the Institute of Molecular Medicine at the Feinstein Institutes and co-director of Research OutSmarts Endometriosis (ROSE) study Sangeeta Chavan, PhD, professor at the Feinstein Institutes for Medical Research
Embed this episode
What this episode covers
As 2022 comes to a close, we look back on five exciting medical advances that made strides against endometriosis, diabetes, lupus, pancreatic cancer and (yes) Covid-19. Chapters: 02:05 – Treating pancreatic cancer in a petri dish | Matthew Weiss, MD Learn more: https://www.northwell.edu/news/the-latest/organoids-may-predict-effective-chemotherapy-treatment 05:51 – A powerful lupus treatment in the pipeline | Richard Furie, MD https://www.northwell.edu/news/the-latest/experimental-lupus-therapy-shows-promise-feinstein-trial 10:25 – Famotidine for Covid | Tobias Janowitz, MD, PhD https://feinstein.northwell.edu/news/the-latest/famotidine-clinical-trial-shows-reduction-covid-19-symptoms 14:45 – A noninvasive test for endometriosis | Christine Metz, PhD https://www.northwell.edu/news/insights/endometriosis-researchers-one-step-closer-to-diagnosing-condition-with-menstrual-blood 19:12 – Treating diabetes with ultrasound | Sangeeta Chavan, PhD https://feinstein.northwell.edu/news/the-latest/research-team-treats-diabetes-using-ultrasound Meet our guests: Matthew Weiss, MD, professor in the Institute of Cancer Research at the Feinstein Institutes and the deputy physician-in-chief and surgical director in the Cancer Institute at Northwell Health Richard Furie, MD, chief of the Division of Rheumatology at Northwell and global principal investigator on the LILAC (Part A) clinical trial Tobias Janowitz, MD, PhD, assistant Professor and Cancer Center Member, Cold Spring Harbor Laboratory; principal investigator of the trial studying famotidine for Covid Christine Metz, PhD, professor in the Institute of Molecular Medicine at the Feinstein Institutes and co-director of Research OutSmarts Endometriosis (ROSE) study Sangeeta Chavan, PhD, professor at the Feinstein Institutes for Medical Research
NOW PLAYING
Top 5 medical innovations of 2022
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.